A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
SARS-CoV-2 변이체에 대한 광범위 중화 인간화 ACE2 표적 항체
Article
[키워드] ACE2 complexes
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Administered
against SARS-CoV
alleviate
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
angiotensin-converting enzyme-2
antibody
Antibody therapy
blocking antibody
blood pressure
circulating
complexes
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
domain
dosage
effective therapy
epitope
event
exhibit
hACE2
hindrance
humanized
in vitro
Infection
inhibitory activity
injection
Injections
Intervention
Isolation
limit
Lineage
lineages
monoclonal antibody
morbidity
morbidity and mortality
Neutralizing
pandemic
Prevent
prophylactically
RBD
receptor
Receptor-binding domain
respiratory
risk
SARS-CoV-2
SARS-CoV-2 lineage
SARS-CoV-2 replication
SARS-CoV-2 variant
SARS-related coronavirus
SARS-related coronaviruses
SARSr-CoVs
significant changes in
Spread
Structure
structures
therapeutic
Transmission
variants
[DOI] 10.1038/s41467-021-25331-x PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-021-25331-x PMC 바로가기 [Article Type] Article